BioMotiv, an accelerator formed out of Ohio-based University Hospitals, has announced a partnership with venture firm Torrey Pines Investment to boost new biotech firm. Under the terms of the deal, BioMotiv will receive up to $20m to support research and development of new firms coming through its doors. In return, Torrey Piunes will have access…
BioMotiv’s millions for biotech
Aug 13, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024